Business Description
Mizuho Medy Co Ltd
ISIN : JP3885900005
Description
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.83 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.25 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.8 | |||||
| 3-Year EBITDA Growth Rate | 106.2 | |||||
| 3-Year EPS without NRI Growth Rate | 131 | |||||
| 3-Year FCF Growth Rate | 165.7 | |||||
| 3-Year Book Growth Rate | 60.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.42 | |||||
| 9-Day RSI | 58.8 | |||||
| 14-Day RSI | 54.93 | |||||
| 6-1 Month Momentum % | 11.69 | |||||
| 12-1 Month Momentum % | 45.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.15 | |||||
| Quick Ratio | 6.45 | |||||
| Cash Ratio | 4.45 | |||||
| Days Inventory | 184.3 | |||||
| Days Sales Outstanding | 121.55 | |||||
| Days Payable | 49.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.57 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| 3-Year Dividend Growth Rate | 128.9 | |||||
| Forward Dividend Yield % | 4.76 | |||||
| 5-Year Yield-on-Cost % | 36.62 | |||||
| Shareholder Yield % | 3.63 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.47 | |||||
| Operating Margin % | 46.88 | |||||
| Net Margin % | 34.34 | |||||
| FCF Margin % | 33.87 | |||||
| ROE % | 26.27 | |||||
| ROA % | 21.26 | |||||
| ROIC % | 53.09 | |||||
| ROC (Joel Greenblatt) % | 91.74 | |||||
| ROCE % | 33.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.47 | |||||
| PE Ratio without NRI | 8.47 | |||||
| Shiller PE Ratio | 14.96 | |||||
| Price-to-Owner-Earnings | 6.28 | |||||
| PEG Ratio | 0.15 | |||||
| PS Ratio | 2.9 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.04 | |||||
| Price-to-Free-Cash-Flow | 8.59 | |||||
| Price-to-Operating-Cash-Flow | 8.02 | |||||
| EV-to-EBIT | 4.25 | |||||
| EV-to-EBITDA | 4.25 | |||||
| EV-to-Revenue | 1.98 | |||||
| EV-to-FCF | 5.73 | |||||
| Price-to-Projected-FCF | 0.69 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.34 | |||||
| Price-to-Graham-Number | 0.88 | |||||
| Price-to-Net-Current-Asset-Value | 2.46 | |||||
| Price-to-Net-Cash | 4.66 | |||||
| Earnings Yield (Greenblatt) % | 23.57 | |||||
| FCF Yield % | 11.62 | |||||
| Forward Rate of Return (Yacktman) % | 28.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mizuho Medy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 10,989.735 | ||
| EPS (TTM) (円) | 396.268 | ||
| Beta | 0.69 | ||
| Volatility % | 44.5 | ||
| 14-Day RSI | 54.93 | ||
| 14-Day ATR (円) | 49.24774 | ||
| 20-Day SMA (円) | 3337 | ||
| 12-1 Month Momentum % | 45.8 | ||
| 52-Week Range (円) | 2010 - 3890 | ||
| Shares Outstanding (Mil) | 9.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mizuho Medy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mizuho Medy Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mizuho Medy Co Ltd Frequently Asked Questions
What is Mizuho Medy Co Ltd(TSE:4595)'s stock price today?
The current price of TSE:4595 is 円3360.00. The 52 week high of TSE:4595 is 円3890.00 and 52 week low is 円2010.00.
When is next earnings date of Mizuho Medy Co Ltd(TSE:4595)?
The next earnings date of Mizuho Medy Co Ltd(TSE:4595) is .
Does Mizuho Medy Co Ltd(TSE:4595) pay dividends? If so, how much?
The Dividend Yield %  of Mizuho Medy Co Ltd(TSE:4595) is 3.57% (As of Today), Highest Dividend Payout Ratio of Mizuho Medy Co Ltd(TSE:4595) was 0.33. The lowest was 0.17. And the median was 0.3. The  Forward Dividend Yield % of Mizuho Medy Co Ltd(TSE:4595) is 4.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers